Cdh1 Regulates Cell Cycle through Modulating the Claspin/Chk1 and the Rb/E2F1 Pathways

被引:56
|
作者
Gao, Daming [1 ]
Inuzuka, Hiroyuki [1 ]
Korenjak, Michael [3 ,4 ]
Tseng, Alan [1 ]
Wu, Tao [2 ]
Wan, Lixin [1 ]
Kirschner, Marc [2 ]
Dyson, Nicholas [3 ,4 ]
Wei, Wenyi [1 ]
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02215 USA
[3] Massachusetts Gen Hosp, Charlestown, MA 02129 USA
[4] Harvard Univ, Sch Med, Charlestown, MA 02129 USA
基金
美国国家卫生研究院;
关键词
ANAPHASE-PROMOTING COMPLEX; DNA-DAMAGE; UBIQUITIN LIGASE; INDUCED SENESCENCE; BINDING-PROTEIN; G(1) ARREST; CHECKPOINT; P53; DEGRADATION; ACTIVATION;
D O I
10.1091/mbc.E09-01-0092
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
APC/Cdh1 is a major cell cycle regulator and its function has been implicated in DNA damage repair; however, its exact role remains unclear. Using affinity purification coupled with mass spectrometry, we identified Claspin as a novel Cdh1-interacting protein and further demonstrated that Claspin is a novel Cdh1 ubiquitin substrate. As a result, inactivation of Cdh1 leads to activation of the Claspin/Chk1 pathway. Previously, we demonstrated that Rb interacts with Cdh1 to influence its ability to degrade Skp2. Here, we report that Cdh1 reciprocally regulates the Rb pathway through competing with E2F1 to bind the hypophosphorylated form of Rb. Although inactivation of Cdh1 in HeLa cells, with defective p53/Rb pathways, led to premature S phase entry, acute depletion of Cdh1 in primary human fibroblasts resulted in premature senescence. Acute loss of many other major tumor suppressors, including PTEN and VHL, also induces premature senescence in a p53- or Rb-dependent manner. Similarly, we showed that inactivation of the p53/Rb pathways by overexpression of SV40 LT-antigen partially reversed Cdh1 depletion-induced growth arrest. Therefore, loss of Cdh1 is only beneficial to cells with abnormal p53 and Rb pathways, which helps explain why Cdh1 loss is not frequently found in many tumors.
引用
收藏
页码:3305 / 3316
页数:12
相关论文
共 50 条
  • [21] CHK1 inhibition synergizes with cisplatin to promote mitotic cell death via activation of caspase 2 and downregulation of E2F1 in small cell lung cancer
    Hsu, Wei-Hsun
    Zhao, Xiaoliang
    Kim, In-Gyu
    Rao, Guanhua
    McCutcheon, Justine
    Hsu, Shuo-Tse
    Dowlati, Afshin
    Zhang, Yu-Wen
    Giaccone, Giuseppe
    CANCER RESEARCH, 2017, 77
  • [22] Chk1-mediated phosphorylation of Cdh1 promotes the SCFβTRCP-dependent degradation of Cdh1 during S-phase and efficient cell-cycle progression
    Pal, Debjani
    Torres, Adrian E.
    Stromberg, Benjamin R.
    Messina, Abbey L.
    Dickson, Andrew S.
    De, Kuntal
    Willard, Belinda
    Venere, Monica
    Summers, Matthew K.
    CELL DEATH & DISEASE, 2020, 11 (04)
  • [23] The 1.7 Å crystal structure of human cell cycle checkpoint kinase Chk1:: Implications for Chk1 regulation
    Chen, P
    Luo, C
    Deng, YL
    Ryan, K
    Register, J
    Margosiak, S
    Tempczyk-Russell, A
    Nguyen, B
    Myers, P
    Lundgren, K
    Kan, CC
    O'Connor, PM
    CELL, 2000, 100 (06) : 681 - 692
  • [24] E2F1 proteolysis via SCF-cyclin F underlies synthetic lethality between cyclin F loss and Chk1 inhibition
    Burdova, Kamila
    Yang, Hongbin
    Faedda, Roberta
    Hume, Samuel
    Chauhan, Jagat
    Ebner, Daniel
    Kessler, Benedikt M.
    Vendrell, Iolanda
    Drewry, David H.
    Wells, Carrow, I
    Hatch, Stephanie B.
    Dianov, Grigory L.
    Buffa, Francesca M.
    D'Angiolella, Vincenzo
    EMBO JOURNAL, 2019, 38 (20):
  • [25] Many pathways to apoptosis: E2F1 regulates splicing of apoptotic genes
    K Korotayev
    D Ginsberg
    Cell Death & Differentiation, 2008, 15 : 1813 - 1814
  • [26] Many pathways to apoptosis: E2F1 regulates splicing of apoptotic genes
    Korotayev, K.
    Ginsberg, D.
    CELL DEATH AND DIFFERENTIATION, 2008, 15 (12): : 1813 - 1814
  • [27] RB/E2F1 in the crossroad of autophagy and apoptosis
    Jiang, Hong
    Martin, Vanesa
    Gomez-Manzano, Candelaria
    Johnson, David G.
    Alonso, Marta
    White, Erin J.
    Xu, Jing
    McDonnell, Timothy J.
    Shinojinna, Naoki
    Fueyo, Juan
    CANCER RESEARCH, 2010, 70
  • [28] Mechanism of CHK2-mediated stabilization of E2F1
    Aoki, Ichiro
    Ogawara, Yoko
    Masuyama, Norihisa
    Gotoh, Yukiko
    CELL STRUCTURE AND FUNCTION, 2005, 30 : 81 - 81
  • [29] Mutational analysis of Chk1, Chk2, Apaf1 and Rb1 in human malignant melanoma cell lines
    Papp, Thilo
    Niemetz, Annett
    Dosdahl, Nils
    Kumar, Krishan
    Schiffmann, Dietmar
    ONCOLOGY REPORTS, 2007, 17 (01) : 135 - 140
  • [30] LIMD1 antagonizes E2F1 activity and cell cycle progression by enhancing Rb function in cancer cells
    Mayank, Adarsh K.
    Sharma, Shipra
    Deshwal, Ravi K.
    Lal, Sunil K.
    CELL BIOLOGY INTERNATIONAL, 2014, 38 (07) : 809 - 817